Shniakat, W.N. (2023) “Cytotoxic Evaluation of Doxorubicin Combination with Baicalein and Resveratrol Against Hct116 and Hepg2 Cancer Cell Lines (Conference Paper) #”, Iraqi Journal of Pharmaceutical Sciences, 31(Suppl.), pp. 92–99. doi:10.31351/vol31issSuppl.pp92-99.